Literature DB >> 26408802

Autoimmune disease and vaccination: impact on infectious disease prevention and a look at future applications.

John E McKinnon1, Kathleen Maksimowicz-McKinnon2.   

Abstract

Vaccines hold promise both for the prevention of infections and as potential immunologic therapy for patients with autoimmune disease (AD). These patients are at high risk for both common and opportunistic infections, but this risk can be significantly reduced and even obviated with the use of recommended available vaccines. Unfortunately, patients with ADs are not routinely offered or provided indicated vaccinations and have higher rates of complications from vaccine-preventable illnesses than patients without ADs. In addition, vaccine therapy is currently under study for the treatment of autoimmune disorders, with early studies demonstrating immunomodulatory effects that may counter undesired immune activation and alleviate disease activity.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26408802     DOI: 10.1016/j.trsl.2015.08.008

Source DB:  PubMed          Journal:  Transl Res        ISSN: 1878-1810            Impact factor:   7.012


  7 in total

1. 

Authors:  Norbert Wagner; Frauke Assmus; Gabriele Arendt; Erika Baum; Ulrich Baumann; Christian Bogdan; Gerd Burchard; Dirk Föll; Edeltraut Garbe; Jane Hecht; Ulf Müller-Ladner; Tim Niehues; Klaus Überla; Sabine Vygen-Bonnet; Thomas Weinke; Miriam Wiese-Posselt; Michael Wojcinski; Fred Zepp
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2019-04       Impact factor: 1.513

2.  Immunizations with Enterotoxigenic Escherichia coli Heat-Stable Toxin Conjugates Engender Toxin-Neutralizing Antibodies in Mice That Also Cross-React with Guanylin and Uroguanylin.

Authors:  Yuleima Diaz; Morten L Govasli; Ephrem Debebe Zegeye; Halvor Sommerfelt; Hans Steinsland; Pål Puntervoll
Journal:  Infect Immun       Date:  2019-06-20       Impact factor: 3.441

3.  Vaccination Guidelines for Patients with Immune-Mediated Disorders on Immunosuppressive Therapies-Executive Summary.

Authors:  Kim A Papp; Boulos Haraoui; Deepali Kumar; John K Marshall; Robert Bissonnette; Alain Bitton; Brian Bressler; Melinda Gooderham; Vincent Ho; Shahin Jamal; Janet E Pope; A Hillary Steinhart; Donald C Vinh; John Wade
Journal:  J Can Assoc Gastroenterol       Date:  2019-02-01

4.  Vaccination Guidelines for Patients With Immune-Mediated Disorders on Immunosuppressive Therapies.

Authors:  Kim A Papp; Boulos Haraoui; Deepali Kumar; John K Marshall; Robert Bissonnette; Alain Bitton; Brian Bressler; Melinda Gooderham; Vincent Ho; Shahin Jamal; Janet E Pope; A Hillary Steinhart; Donald C Vinh; John Wade
Journal:  J Cutan Med Surg       Date:  2018-11-21       Impact factor: 2.092

Review 5.  [Is complete immunity against measles a realistic target for patients with rheumatic diseases and how can it possibly be achieved?]

Authors:  J Braun; U Kiltz; U Müller-Ladner
Journal:  Z Rheumatol       Date:  2020-09-18       Impact factor: 1.372

Review 6.  An evidence-based guide to SARS-CoV-2 vaccination of patients on immunotherapies in dermatology.

Authors:  Louise M Gresham; Barbara Marzario; Jan Dutz; Mark G Kirchhof
Journal:  J Am Acad Dermatol       Date:  2021-01-19       Impact factor: 11.527

Review 7.  The Autoimmune Ecology.

Authors:  Juan-Manuel Anaya; Carolina Ramirez-Santana; Maria A Alzate; Nicolas Molano-Gonzalez; Adriana Rojas-Villarraga
Journal:  Front Immunol       Date:  2016-04-26       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.